Almirall SA logo

Almirall SA

ALMRY · OTC · Health Technology, Pharmaceuticals: Major · Founded 1944

Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.

Current Price
—
Market Cap
—
Return Since Last Split
-3%
Last Split
May 22, 2026
Total Splits
1
Cumulative Multiple
1.02×

What If You Bought ALMRY Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
102 shares · 1×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
May 22, 2026$14.0766-for-651.02×1.02×

Almirall SA Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Almirall SA's latest record in the split calendar is a 66-for-65 forward split effective 2026-05-22.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.